Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) is bringing a reformulated version of its leading CBD brand Sollievo to the market.
Sollievo, which in Italian means ‘relief,’ is a non-GMO, non-psychoactive CBD tincture that has rapid bioavailability and is derived from USA-grown hemp.
The updated formulations contain three times the amount of CBD per unit, packing a more potent punch in each dosage.
"We have spent the last few months dramatically increasing the potency, flavour profiles, and profitability of the Sollievo tincture product lines,” said Dustin Klein, senior vice president, business development at Empower Clinics.
"Our new formulations were manufactured in a state-of-the-art CGMP facility, ensuring quality and consistency, and by tripling the amount of CBD per unit to 900mg, it provides a more potent single dose to our customers, to our patients."
The four tincture lines – Chronic Pain, Digestion, Insomnia and Anxiety – are available at the Sun Valley Health wellness clinics and online, Empower said in a statement.
The wellness brand also said it was awarded its 2020 Oregon Department of Agriculture hemp handlers license, which means its new extraction and production facility in Sandy is compliant with state regulations.
"I'm excited to have our new Sollievo tinctures available for purchase, and so proud of Dustin and our team who have brought an exemplary product to market,” said Steven McAuley, Empower’s CEO.
"Having the hemp handlers license in place for 2020 and continuing toward the close of our Heritage Cannabis joint venture, allows us to control our supply chain and to bring best-in-class CBD products to domestic and international markets."
Empower also said that Mat Lee’s position as CFO has concluded and thanked him for his contributions to the firm. The firm said it is searching for a new finance chief.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas